ARTICLE | Company News
Ganymed, Astellas deal
November 2, 2016 5:54 PM UTC
Astellas will acquire cancer company Ganymed for €422 million ($459.4 million) in cash. Ganymed shareholders are also eligible for up to €860 million ($936.2 million) in undisclosed milestones tied to...
BCIQ Target Profiles